I believe Baker Brothers reduced their AMRN position in the 4th quarter.

They still lost so much money on the patent ruling. All the way from the 20's to $4 today after they lost.

Yep, 41,544,288 which is their 5th largest holding as of November 2019.

I believe Baker Brothers reduced their AMRN position in the 4th quarter.

Are Baker Brothers still invested in AMRN after such a poor performance post label expansion?

Yep, 41,544,288 which is their 5th largest holding as of November 2019.

Here's the details of their Amarin position:

Are Baker Brothers still invested in AMRN after such a poor performance post label expansion?

Here's the details of their Amarin position:

Perceptive is a legendary biotech fund.

Who’s better: Baker Brothers or Perceptive?

The other big biotech hedge fund is Perceptive Advisors.

Perceptive is a legendary biotech fund.

And their biggest position, Amarin, could potentially add to their gains in a big way with AdCom next week and potential expanded Vascepa labeling in December. Makes me wonder what is their next big play?

Baker Brothers are about to make a killing on their Amarin stake. According to their most recent filing, they have over 41M at an estimated average price of $8.93. Doing the math makes me sick. I stand to make a lot after the expanded labeling and buyout longterm but nothing like the money they are going to make. Very impressive set of investors.

Amarin Receives FDA Approval for Expanded Labeling

Sorry....can't get over the fact that they made $1.4 billion in two weeks with their investment in biotech companies.

The other big biotech hedge fund is Perceptive Advisors.

What are some of Baker Brothers' most recent positions? I don't want to chase something they purchase years ago.

Whalewisdom has good info and is current -

What are some of Baker Brothers' most recent positions? I don't want to chase something they purchase years ago.

Where can you find a list of their positions?

And their biggest position, Amarin, could potentially add to their gains in a big way with AdCom next week and potential expanded Vascepa labeling in December. Makes me wonder what is their next big play?

Where can you find a list of their positions?

Sorry....can't get over the fact that they made $1.4 billion in two weeks with their investment in biotech companies.

And their biggest position, Amarin, could potentially add to their gains in a big way with AdCom next week and potential expanded Vascepa labeling in December. Makes me wonder what is their next big play?